Literature DB >> 18562179

Association of HLA-DQA1 and DQB1 alleles with keloids in Chinese Hans.

Wen-Sheng Lu1, Jian-Feng Wang, Sen Yang, Feng-Li Xiao, Cheng Quan, Hui Cheng, Pei-Guang Wang, An-Ping Zhang, Li-Qiong Cai, Xue-Jun Zhang.   

Abstract

BACKGROUND: Some studies have suggested that human HLA status might potentiate development of keloids phenotype, and exists ethnic differences. No report has been published about HLA-DQA1 and DQB1 alleles associated with keloids in Chinese Hans.
OBJECTIVES: To investigate whether HLA-DQA1 and DQB1 alleles are associated with genetic susceptibility to keloids in Chinese Hans.
METHODS: Polymerase chain reaction-sequence-specific primer (PCR-SSP) method was used to analyze the distribution of HLA-DQA1 and DQB1 alleles among 192 patients with keloids and 273 healthy controls in Chinese Hans.
RESULTS: (1) The frequencies of HLA-DQA1*0104, DQB1*0501 and DQB1*0503 (OR = 2.13, P(c) = 0.0063; OR = 14.42, P(c) < 10(-7) and OR = 6.09, P(c) < 10(-7), respectively) were significantly higher, while the frequencies of DQA1*0501, DQB1*0201 and DQB1*0402 (OR = 0.46, P(c) = 0.0099; OR = 0.24, P(c) < 10(-4) and OR = 0.10, P(c)=0.0054, respectively) were lower in patients than in controls. (2) In this study significant susceptibility haplotypes to keloids were DQA1*0104-DQB1*0501 and DQA1*0104-DQB1*0503. (3) HLA-DQB1*0501 and DQB1*0503 were positively associated with all subgroups of keloid patients. However, the DQA1*0104 (OR = 2.51, P(c) = 0.0009; OR = 2.22, P(c) = 0.0090 and OR = 2.20, P(c) = 0.0117, respectively) was only prevalent in keloid patients with single site, moderate severity and negative family history. (4) HLA-DQB1*0201 (OR = 0.27, P(c) = 0.0018 and OR = 0.27, P(c) = 0.0012, respectively) and DQB1*0402 (OR = 0.07, P(c) = 0.0270 and OR = 0.07, P(c) = 0.0306, respectively) were negatively associated with moderate severity and negative family history in keloids, moreover, HLA-DQB1*0201 (OR = 0.23, P(c) = 0.0003) and DQA1*0501 (OR = 0.43, P(c) = 0.0234) were less prevalent in patients with single site.
CONCLUSION: This study demonstrated the positive association of HLA-DQA1 and DQB1 alleles and haplotypes with keloids.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18562179     DOI: 10.1016/j.jdermsci.2008.04.010

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  9 in total

Review 1.  Advances in the pathogenesis and clinical application prospects of tumor biomolecules in keloid.

Authors:  Yijun Xia; Youbin Wang; Mengjie Shan; Yan Hao; Hao Liu; Qiao Chen; Zhengyun Liang
Journal:  Burns Trauma       Date:  2022-06-25

2.  Downregulated cytotoxic CD8+ T-cell identifies with the NKG2A-soluble HLA-E axis as a predictive biomarker and potential therapeutic target in keloids.

Authors:  Heng Xu; Zhu Zhu; Jian Hu; Jiawei Sun; Yan Wo; Xianshu Wang; Hongzhi Zou; Bin Li; Yixin Zhang
Journal:  Cell Mol Immunol       Date:  2022-01-17       Impact factor: 22.096

Review 3.  Genetic architecture of human fibrotic diseases: disease risk and disease progression.

Authors:  Agnès Gardet; Timothy S Zheng; Joanne L Viney
Journal:  Front Pharmacol       Date:  2013-12-18       Impact factor: 5.810

4.  Chemokine-Like Factor 1 (CKLF-1) is Overexpressed in Keloid Patients: A Potential Indicating Factor for Keloid-Predisposed Individuals.

Authors:  Mingzi Zhang; Ying Xu; Yifang Liu; Yingying Cheng; Pengxiang Zhao; Hao Liu; Youbin Wang; Xuemei Ma
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

5.  Hyperbaric oxygen therapy can ameliorate the EMT phenomenon in keloid tissue.

Authors:  Mingzi Zhang; Shu Liu; Enling Guan; Hao Liu; Xinhang Dong; Yan Hao; Xin Zhang; Pengxiang Zhao; Xuehua Liu; Shuyi Pan; Youbin Wang; Xiaojun Wang; Yifang Liu
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

6.  Iatrogenic subglottic tracheal stenosis after tracheostomy and endotracheal intubation: A cohort observational study of more severity in keloid phenotype.

Authors:  Enqiang Chang; Lingzhi Wu; Joe Masters; Jie Lu; Shengli Zhou; Wenli Zhao; Mingyang Sun; Fanmin Meng; Chen Pac Soo; Jiaqiang Zhang; Daqing Ma
Journal:  Acta Anaesthesiol Scand       Date:  2019-04-14       Impact factor: 2.105

7.  Management of Spontaneous and Pruritic Keloids: A Case Report.

Authors:  Chantae C Hollis; Ariful Alam; Stephanie Pelenyi; Rio Varghese; Nyrie Mann; Chika Kanu-Ivi; Raghu H Nagaraj; Kasi Penumarthi; Maria J Prince; Juaquito Jorge; Frederick Tiesenga
Journal:  Cureus       Date:  2022-03-16

Review 8.  The Emerging Therapeutic Targets for Scar Management: Genetic and Epigenetic Landscapes.

Authors:  Sara Amjadian; Sharif Moradi; Parvaneh Mohammadi
Journal:  Skin Pharmacol Physiol       Date:  2022-06-13       Impact factor: 3.014

9.  Is There an Association between Keloids and Blood Groups?

Authors:  Abas Mouhari-Toure; Bayaki Saka; Koussaké Kombaté; Sefako Akakpo; Palakiyem Egbohou; Kissem Tchangaï-Walla; Palokinam Pitche
Journal:  ISRN Dermatol       Date:  2012-12-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.